Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
 Home | Pathology Group MembersOur Hospital  Search This Website:
        H&E plus IHC: which CRC Therapeutic response is expected?
      

In addition to diligent staging in hopes of assuring that (1) a worse-stage situation is not missed during surgical pathology grossing and final interpretation, it is valuable to survival of the patient to diligently portray two other assessments of CRC cases. (2) Detection of high-risk histology features and (3) giving an up-front opinion as to the general molecular/genetic variant. And, spercific molecular mutations are subsequently ordered as needed. Here is the chart of factors to allow a strong probability (wager) opinion as to general molecular/genetic variant (especially the common chromosome instability variant vs. other variants:

     

 

 

References/links:

  1. see references on the above table.

(posted 1 October 2012)

 
© Copyright 1999 - 2006, all rights reserved, Pathology Associates Of Lexington, P.A.